For BC HCC development, male gender (HR: 5.813, 95% CI: 1.260–26.810, p = 0.024) and AFP ≥ 15 ng/mL (7.941, 2.119–29.756, p = 0.002) were independent risk factors. This evidence concerns the gene AFP and hepatocellular carcinoma.